A phase III randomised study comparing concomitant radiochemotherapy as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer

Lung Cancer

Volumn 64, Issue 2, 2009, Pages 187-193

  Berghmans, T ^a   Van Houtte, P ^a   Paesmans, M ^a   Giner, V ^b   Lecomte, J ^c   Koumakis, G ^d   Richez, M ^e   Holbrechts, S ^f   Roelandts, M ^a   Meert, A P ^a   Alard, S ^g   Leclercq, N ^a   Sculier, J P ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b HOSPITAL DE SAGUNTO   (Spain)

^c Hospital Civil Charleroi   (Belgium)

^d St Savas Hospital Hellenic Cancer Institute   (Greece)

^e Clinique Saint Joseph at Mons   (Belgium)

^f Centre Hospitalier Universitaire Ambroise Pare   (Belgium)

^g SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Chemotherapy; Cisplatin; Gemcitabine; Non small cell lung carcinoma; Radiotherapy; Vinorelbine

Indexed keywords

CISPLATIN; DOCETAXEL; GEMCITABINE; NAVELBINE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ESOPHAGITIS; FEBRILE NEUTROPENIA; FEMALE; HEARING LOSS; HEART DISEASE; HEART FAILURE; HUMAN; INFECTION; INTERMETHOD COMPARISON; KIDNEY DISEASE; LEUKOPENIA; LUNG EMBOLISM; LUNG INFECTION; LUNG NON SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROLOGIC DISEASE; NEUTROPHIL; PERIPHERAL NEUROPATHY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; SIDE EFFECT; SKIN DISEASE; STOMATITIS; THROMBOCYTE; THROMBOCYTOPENIA; TREATMENT RESPONSE; URINARY TRACT DISEASE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOTHERAPY; VINBLASTINE;

EID: 63249091349     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.08.004     Document Type: Article

References (59)

1. Berghmans T., Paesmans M., Meert A.P., Mascaux C., Lothaire P., Lafitte J.J., et al. Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature. Lung Cancer 49 (2005) 13-23
2. Sculier J.P. Traitement en oncologie thoracique-l'apport des méta-analyses. Rev Mal Respir 22 (2005) 8S81-18S
3. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995;311:899-909.
4. Beslija S., Dizdarevic Z., Lomigoric J., Zutic H., Musanovic M., Mehic B., et al. Randomized phase II study of induction chemotherapy with gemcitabine plus cisplatin followed by sequential radiotherapy versus radiotherapy alone in patients with stage III non-small cell lung cancer. J BUON 10 (2005) 347-355
5. Brodin O., Nou E., Mercke C., Linden C.J., Lundstrom R., Arwidi A., et al. Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung. The Swedish Lung Cancer Study Group. Eur J Cancer 32A (1996) 1893-1900
6. Crino L., Latini P., Meacci M., Corgna E., Maranzano E., Darwish S., et al. Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer. Ann Oncol 4 (1993) 847-851
7. Cullen M.H., Billingham L.J., Woodroffe C.M., Chetiyawardana A.D., Gower N.H., Joshi R., et al. Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life. J Clin Oncol 17 (1999) 3188-3194
8. Dillman R.O., Seagren S.L., Propert K.J., Guerra J., Eaton W.L., Perry M.C., et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323 (1990) 940-945
9. Dillman R.O., Herndon J., Seagren S.L., Eaton Jr. W.L., and Green M.R. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst 88 (1996) 1210-1215
10. Gregor A., Macbeth F.R., Paul J., Cram L., and Hansen H.H. Radical radiotherapy and chemotherapy in localized inoperable non-small-cell lung cancer: a randomized trial. J Natl Cancer Inst 85 (1993) 997-999
11. LeChevalier T., Arriagada R., Quoix E., Ruffie P., Martin M., Tarayre M., et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83 (1991) 417-423
12. LeChevalier T., Arriagada R., Tarayre M., Lacombe-Terrier M.J., Laplanche A., Quoix E., et al. Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma. J Natl Cancer Inst 84 (1992) 58
13. Mattson K., Holsti L.R., Holsti P., Jakobsson M., Kajanti M., Liippo K., et al. Inoperable non-small cell lung cancer: radiation with or without chemotherapy. Eur J Cancer Clin Oncol 24 (1988) 477-482
14. Mattson K.V., Abratt R.P., ten V.G., and Krofta K. Docetaxel as neoadjuvant therapy for radically treatable stage III non-small-cell lung cancer: a multinational randomised phase III study. Ann Oncol 14 (2003) 116-122
15. Morton R.F., Jett J.R., McGinnis W.L., Earle J.D., Therneau T.M., Krook J.E., et al. Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial. Ann Intern Med 115 (1991) 681-686
16. Planting A., Helle P., Drings P., Dalesio O., Kirkpatrick A., McVie G., et al. A randomized study of high-dose split course radiotherapy preceded by high-dose chemotherapy versus high-dose radiotherapy only in locally advanced non-small-cell lung cancer. An EORTC Lung Cancer Cooperative Group trial. Ann Oncol 7 (1996) 139-144
17. Sause W., Kolesar P., Taylor IV S., Johnson D., Livingston R., Komaki R., et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 117 (2000) 358-364
18. Sause W.T., Scott C., Taylor S., Johnson D., Livingston R., Komaki R., et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 87 (1995) 198-205
19. Van Houtte P., Klastersky J., Renaud A., Michel J., Vandermoten G., Nguyen H., et al. Induction chemotherapy with cisplatin, etoposide and vindesine before radiation therapy for non-small cell lung cancer. A randomized study. In: Arriagada R. (Ed). Treatment modalities in lung cancer (1988), Karger, Basel 131-137
20. Wolf M., Hans K., Becker H., Hassler R., vonBultzingslowen F., Goerg R., et al. Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer. Semin Oncol 21 (1994) 42-47
21. Sculier J.P., Berghmans T., Paesmans M., Branle F., Lemaitre F., Mascaux C., et al. Le rôle de la chimiothérapie dans le traitement des cancers bronchiques non à petites cellules, non métastatiques. Rev Med Brux 22 (2001) 477-487
22. Ball D., Bishop J., Smith J., O'Brien P., Davis S., Ryan G., et al. A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial. Radiother Oncol 52 (1999) 129-136
23. Blanke C., Ansari R., Mantravadi R., Gonin R., Tokars R., Fisher W., et al. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol. J Clin Oncol 13 (1995) 1425-1429
24. Bonner J.A., McGinnis W.L., Stella P.J., Marschke Jr. R.F., Sloan J.A., Shaw E.G., et al. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study. Cancer 82 (1998) 1037-1048
25. Cakir S., and Egehan I. A randomised clinical trial of radiotherapy plus cisplatin versus radiotherapy alone in stage III non-small cell lung cancer. Lung Cancer 43 (2004) 309-316
26. Clamon G., Herndon J., Cooper R., Chang A.Y., Rosenman J., and Green M.R. Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group. J Clin Oncol 17 (1999) 4-11
27. Groen H.J., van der Leest A.H., Fokkema E., Timmer P.R., Nossent G.D., Smit W.J., et al. Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study. Ann Oncol 15 (2004) 427-432
28. Jeremic B., Shibamoto Y., Acimovic L., and Djuric L. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer. J Clin Oncol 13 (1995) 452-458
29. Jeremic B., Shibamoto Y., Acimovic L., and Milisavljevic S. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study. J Clin Oncol 14 (1996) 1065-1070
30. Schaake-Koning C., van den B.W., Dalesio O., Festen J., Hoogenhout J., van H.P., et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326 (1992) 524-530
31. Soresi E., Clerici M., Grilli R., Borghini U., Zucali R., Leoni M., et al. A randomized clinical trial comparing radiation therapy v radiation therapy plus cis-dichlorodiammine platinum (II) in the treatment of locally advanced non-small cell lung cancer. Semin Oncol 15 (1988) 20-25
32. Trovo M.G., Minatel E., Franchin G., Boccieri M.G., Nascimben O., Bolzicco G., et al. Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 24 (1992) 11-15
33. Rowell N.P., and O'rourke N.P. Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev (2004) CD002140
34. Furuse K., Fukuoka M., Kawahara M., Nishikawa H., Takada Y., Kudoh S., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17 (1999) 2692-2699
35. Komaki R., Seiferheld W., Ettinger D., Lee J.S., Movsas B., and Sause W. Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04. Int J Radiat Oncol Biol Phys 53 (2002) 548-557
36. Zatloukal P., Petruzelka L., Zemanova M., Havel L., Janku F., Judas L., et al. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Lung Cancer 46 (2004) 87-98
37. Fournel P., Robinet G., Thomas P., Souquet P.J., Lena H., Vergnenegre A., et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 Study. J Clin Oncol 23 (2005) 5910-5917
38. Belani C.P., Choy H., Bonomi P., Scott C., Travis P., Haluschak J., et al. Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol. J Clin Oncol 23 (2005) 5883-5891
39. Curran W.J., Scott C., Langer C., Komaki R., Lee J., Hauser S., Movsas B., Wasserman T.H., Rosenthal S., Byhardt R.W., Sause W.T., and Cox J. Phase III comparison of sequential vs. concurrent chemoradiation for PTS with unresected stage III non-small cell lung cancer (NSCLC): initial report of Radiation Therapy Oncology Group (RTOG) 9410. Proc ASCO 19 (2000)
40. Auperin A., Rolland E., Curran W., Furuse K., Fournel P., Belderbos J., et al. Concomitant radio-chemotherapy (RT-CT) versus sequential RT-CT in locally advanced non-small cell lung cancer (NSCLC): a meta-analysis using individual patient data (IPD) from randomised clinical trials (RCTs). J Thorac Oncol 2 8 Suppl. 4 (2007)
41. Gralla R., Harper P., Johnson S., and Delgado F.M. Vinorelbine (navelbine) in the treatment of non-small-cell lung cancer: recent developments in combination chemotherapy and radiotherapy. Ann Oncol 10 Suppl. 5 (1999) S47-S51
42. Vokes E.E., Gregor A., and Turrisi A.T. Gemcitabine and radiation therapy for non-small cell lung cancer. Semin Oncol 25 (1998) 66-69
43. Scalliet P., Goor C., Galdermans D., Van Meerbeek J., Groen H.J., van der Leest A.H., et al. Gemzar (gemcitabine) with thoracic radiotherapy-A phase II pilot study in chemonaive patients with advanced non-small cell lung cancer. Proc ASCO 17 (1998)
44. Goss G., Lochrin C., Perry G., Girard A., Esche B., Iglesias J., et al. A phase I study of gemcitabine and cisplatin with concurrent curative irradiation in stage III non-small cell lung cancer. Proc ASCO 18 (1999)
45. Vokes E.E., Herndon J.E., Crawford J., Leopold K.A., Perry M.C., Miller A.A., et al. Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431. J Clin Oncol 20 (2002) 4191-4198
46. van Putten J.W., Price A., van der Leest A.H., Gregor A., Little F.A., and Groen H.J. A Phase I study of gemcitabine with concurrent radiotherapy in stage III, locally advanced non-small cell lung cancer. Clin Cancer Res 9 (2003) 2472-2477
47. Trodella L., Granone P., Valente S., Turriziani A., Macis G., Corbo G.M., et al. Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small-cell lung cancer. J Clin Oncol 20 (2002) 804-810
48. Sculier J.P., Paesmans M., Lafitte J.J., Baumohl J., Thiriaux J., vanCutsem O., et al. A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy. European Lung Cancer Working Party. Ann Oncol 10 (1999) 295-303
49. Machin D., and Campbell M.J. Statistical tables for the design of clinical trials (1987), Blackwell Scientific Publications, Oxford
50. Garrido P., Arellano A., Massuti B., Andreu J., Juan O., Amador R., et al. Randomized phase II trial using concomitant chemoradiation plus induction (I) or consolidation (C) chemotherapy (CT) for unresectable stage III non-small cell lung cancer (NSCLC) patients (p). Mature results of the SLCG 0008 study. J Thorac Oncol 2 8 Suppl. 4 (2007)
51. Van Meerbeek J., Cardenal F., Vansteenkiste J., Stigt J., Akyol F., De Neve W., et al. Mature results of PulmonArt: involved-field 3D radiotherapy (RT) and docetaxel/cisplatin chemotherapy (CT) in a randomised phase 2 study comparing concurrent CT-RT followed by consolidation CT, with induction CT followed by concurent CT-RT in patients (pts) with stage III non-small cell lung cancer (NSCLC). J Thorac Oncol 2 8 Suppl. 4 (2007)
52. Fournel P., Vergnenegre A., Robinet G., Lena H., Gervais R., Le Caer H., et al. Induction or consolidation chemotherapy with cisplatin and paclitaxel plus concurrent chemo-radiation with cisplatin and vinorelbine for unresectable non-small cell lung cancer patients: randomized phase II trial GFPC-GLOT-IFCT 02-01. J Clin Oncol 24 18S (2006)
53. Caffo O. Radiosensitization with chemotherapeutic agents. Lung Cancer 34 Suppl. 4 (2001) S81-S90
54. Delbaldo C., Michiels S., Syz N., Soria J.C., Le Chevalier T., and Pignon J.P. Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis. JAMA 292 (2004) 470-484
55. Saunders M., Dische S., Barrett A., Harvey A., Griffiths G., and Palmar M. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee. Radiother Oncol 52 (1999) 137-148
56. Sculier J.P., Klastersky J., Giner V., Bureau G., Thiriaux J., Dabouis G., et al. Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party. J Clin Oncol 12 (1994) 353-359
57. Cardenal F., Lopez-Cabrerizo M.P., Anton A., Alberola V., Massuti B., Carrato A., et al. Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 17 (1999) 12-18
58. Crino L., Scagliotti G.V., Ricci S., De Marinis F., Rinaldi M., Gridelli C., et al. Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: a randomized phase III study of the Italian Lung Cancer Project. J Clin Oncol 17 (1999) 3522-3530
59. Sculier J.P., Lafitte J.J., Lecomte J., Berghmans T., Thiriaux J., Florin M.C., et al. A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer. Ann Oncol 13 (2002) 874-882